Literature DB >> 19473831

Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer.

Peter Helmbold1, Christoph Lahtz, Esther Herpel, Philipp A Schnabel, Reinhard H Dammann.   

Abstract

In small cell lung cancer (SCLC), hypermethylation of the tumour suppressor Ras association domain family 1A (RASSF1A) is frequent. It is associated with SV40 polyomaviral infection in other tumours. Merkel cell polyomavirus (MCPyV) infection has been reported in Merkel cell carcinoma (MCC), a neuroendocrine carcinoma with biological similarity to SCLC. In our study, we investigated polyomavirus infection (SV40 and MCPyV) and promoter hypermethylation of the tumour suppressors RASSF1A and p16 in 18 SCLCs (14 primaries and 4 regional lymph node metastases) and 18 blood control samples. MCPyV was found in 39% (7 of 18) of the tumour tissues but not observed in controls. SV40 was not observed in the tumour tissue. RASSF1A promoter hypermethylation (94%; 17 of 18) was more frequent compared to p16 methylation (56%, 10 of 18). We found no significant correlation between RASSF1A or p16 promoter hypermethylation and infection with the investigated polyoma viruses. Our results show a high frequency of hypermethylation of the RASSF1A promoter and occurrence of MCPyV infection in the tumour tissue of SCLC. These events may contribute to the pathogenesis of SCLC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19473831     DOI: 10.1016/j.ejca.2009.04.038

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  27 in total

Review 1.  [Neuroendocrine tumors of the lungs. From small cell lung carcinoma to diffuse idiopathic pulmonary neuroendocrine cell hyperplasia].

Authors:  P A Schnabel; K Junker
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

Review 2.  MCV and Merkel cell carcinoma: a molecular success story.

Authors:  Reety Arora; Yuan Chang; Patrick S Moore
Journal:  Curr Opin Virol       Date:  2012-06-17       Impact factor: 7.090

Review 3.  [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?].

Authors:  P A Schnabel; K Junker
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

4.  Distinct merkel cell polyomavirus molecular features in tumour and non tumour specimens from patients with merkel cell carcinoma.

Authors:  Hélène C Laude; Barbara Jonchère; Eve Maubec; Agnès Carlotti; Eduardo Marinho; Benoit Couturaud; Martine Peter; Xavier Sastre-Garau; Marie-Françoise Avril; Nicolas Dupin; Flore Rozenberg
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

5.  Prior human polyomavirus and papillomavirus infection and incident lung cancer: a nested case-control study.

Authors:  Danny V Colombara; Lisa E Manhart; Joseph J Carter; Stephen E Hawes; Noel S Weiss; James P Hughes; Matt J Barnett; Gary E Goodman; Jennifer S Smith; You-Lin Qiao; Denise A Galloway
Journal:  Cancer Causes Control       Date:  2015-09-28       Impact factor: 2.506

Review 6.  [Grading of neuroendocrine tumors].

Authors:  W Saeger; P A Schnabel; P Komminoth
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

Review 7.  Epigenetic reprogramming of host genes in viral and microbial pathogenesis.

Authors:  Konstantinos Paschos; Martin J Allday
Journal:  Trends Microbiol       Date:  2010-08-18       Impact factor: 17.079

8.  Human polyomaviruses in skin diseases.

Authors:  Ugo Moens; Maria Ludvigsen; Marijke Van Ghelue
Journal:  Patholog Res Int       Date:  2011-09-12

9.  No evidence for WU polyomavirus infection in chronic obstructive pulmonary disease.

Authors:  Felix C Ringshausen; Marei Heckmann; Benedikt Weissbrich; Florian Neske; Irmgard Borg; Umut Knoop; Juliane Kronsbein; Barbara M Hauptmeier; Gerhard Schultze-Werninghaus; Gernot Rohde
Journal:  Infect Agent Cancer       Date:  2009-08-28       Impact factor: 2.965

10.  Detection of Merkel cell polyomavirus with a tumour-specific signature in non-small cell lung cancer.

Authors:  Y Hashida; M Imajoh; Y Nemoto; M Kamioka; A Taniguchi; T Taguchi; M Kume; K Orihashi; M Daibata
Journal:  Br J Cancer       Date:  2013-01-15       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.